New Zealand markets closed

Roivant Sciences Ltd. (ROIV)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.2200+0.0500 (+1.58%)
At close: 04:00PM EDT
3.2250 +0.00 (+0.16%)
After hours: 06:10PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.1700
Bid3.2100 x 800
Ask3.2200 x 3000
Day's range3.1400 - 3.3200
52-week range2.5200 - 16.7600
Avg. volume846,385
Market cap2.268B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Roivant to Participate in September Investor Events

    Three healthcare investor conferences in September across Boston, New York and LondonRoivant Investor Day will take place virtually on September 28th starting at 11 a.m. EDT BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) will participate in three healthcare investor conferences and hold an investor day in September: Citi BioPharma Conference in Boston on Wednesday, September 7thH.C. Wainwright Global Investment Conference

  • GlobeNewswire

    Roivant Sciences Reports Financial Results for the First Quarter Ended June 30, 2022 and Provides Business Update

    Amy Mahery Amy Mahery Early launch data for VTAMA® (tapinarof) with approximately 14,000 prescriptions written by more than 3,000 unique prescribers in initial eleven weeks of launch shows strong demand for first topical novel chemical entity for plaque psoriasis in 25 yearsThe Journal of the American Academy of Dermatology (JAAD) published the Phase 3 long-term extension study highlighting the unique mechanism for the remittive effect of VTAMA showing mean duration off-therapy for patients achi

  • GlobeNewswire

    Roivant Sciences to Report Financial Results for the Quarter Ended June 30, 2022 on Monday, August 15, 2022

    Investor call and webcast scheduled for Monday, August 15 at 8:00 a.m. EDTRoivant will host an investor day on Wednesday, September 28 at 11:00 a.m. EDT BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV), a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it will host a live conference call and webcast at 8:00 a.m. EDT on Monday, August 15, 2022 to report its financi